Search

Your search keyword '"Barbarot S"' showing total 10 results
Start Over Author "Barbarot S" Language undetermined
10 results on '"Barbarot S"'

1. First Update of the Living European Guideline (EuroGuiDerm) on Atopic Eczema

Author

Wollenberg, A, Kinberger, M, Arents, B, Aszodi, N, Barbarot, S, Bieber, T, Brough, H A, Pinton, P Calzavara, Christen-Zaech, S, Deleuran, M, Dittmann, M, Fosse, N, Gáspár, K, Gerbens, L A A, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, C G, Nast, A, Nygaard, U, Rehbinder, E M, Ring, J, Rossi, M, Roxburgh, C, Serra-Baldrich, E, Simon, D, Szalai, Z Z, Szepietowski, J C, Torrelo, A, Werfel, T, and Flohr, C

Subjects
610 Medicine & health
Published
2023
Full Text
View/download PDF

2. Management of tinea capitis in children following the withdrawal of griseofulvin from the French market: A fast-track algorithm proposed by the Center of Evidence of the French Society of Dermatology

Author

Maruani, A, Barbarot, S, Gangneux, J.P., Caseris, M, Moreau, C, Brun, A. S., Botterel, F, Menotti, J, Toubiana, J, Chouchana, L, Beylot‐barry, M, Dupin, N, Guillot, B, Chosidow, O, MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR des Sciences Pharmaceutiques et Biologiques (Nantes Univ - UFR Pharmacie), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Physiopathologie des Adaptations Nutritionnelles (PhAN), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Centre hospitalier universitaire de Nantes (CHU Nantes), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), École des Hautes Études en Santé Publique [EHESP] (EHESP), AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Avicenne [AP-HP], CHI Créteil, Institut des Agents Infectieux [Lyon] (IAI), Hospices Civils de Lyon (HCL), CHU Necker - Enfants Malades [AP-HP], Hôpital Cochin [AP-HP], Bordeaux Research In Translational Oncology [Bordeaux] (BaRITOn), Université de Bordeaux (UB)-CHU Bordeaux [Bordeaux]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Henri Mondor [Créteil], Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR des Sciences Pharmaceutiques et Biologiques (Nantes Université - UFR Pharmacie), CHU Henri Mondor, and Chard-Hutchinson, Xavier

Subjects
[SDV.IB] Life Sciences [q-bio]/Bioengineering, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, Dermatophytes, Tinea capitis, Dermatology, [SDV.MHEP.DERM] Life Sciences [q-bio]/Human health and pathology/Dermatology, Griseofulvin, Treatment, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Children, Terbinafine, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology
Abstract

International audience

Published
2021

3. P14.33 Adult brainstem gliomas in neurofibromatosis type 1 (NF1)

Author

Pierre Wolkenstein, Luc Bauchet, François Ducray, Florence Laigle-Donadey, Jean-Sébastien Guillamo, Wang A, Barbarot S, O Chinot, and D. Frappaz

Subjects
Cancer Research, Pathology, medicine.medical_specialty, business.industry, medicine.disease, nervous system diseases, Poster Presentations, Text mining, Oncology, medicine, Neurology (clinical), Brainstem, Neurofibromatosis, business, neoplasms
Abstract

BACKGROUND The brainstem is the second location of brain tumors after optic pathways in NF1. In NF1 children, brainstem gliomas are usually indolent and have a better prognosis than their counterparts in non NF1 children. In contrast, the natural history and prognosis of adult brainstem gliomas in NF1 are nearly unknown. MATERIAL AND METHODS We conducted a retrospective analysis of medical records and MRI of adult NF1 patients followed for a brainstem glioma in 8 centers over a 17 years period (2000–2017). Clinical and imaging characteristics, management and outcome were analyzed. RESULTS Twenty five patients were included in the study (13 males and 12 females) with a median age of 32 (range 17–58). The epicenter of the tumor was located into the pons n=13 (52%), the mesencephalon n=7 (28%), the medulla oblongata n=5 (20%). On MRI, contrast enhancement was seen in 19 tumors (76%). Pathological examination was available in 13 tumors (52%) and showed a high grade astrocytoma (III or IV) in 9 tumors. Five patients were asymptomatic, 3 remained asymptomatic during the follow-up (median follow-up: 86 months, range 22–124). Twenty patients were symptomatic with a median duration of symptom of 2.5 months (range 1–10) before diagnosis. Among these symptomatic patients, 15 died from tumor progression despite treatment with radiation therapy and or chemotherapy. The median overall survival of symptomatic patients was 36 months. CONCLUSION Brainstem gliomas are rare tumors in adults with NF1. Unlike children, adult brainstem gliomas seem to have an unexpected poor prognosis, suggesting the disease may be different in adulthood.

Published
2019

4. Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups

Author

Mazereeuw-Hautier, J, Dreyfus, I., Barbarot, S., Serrentino, L., Bourdon-Lanoy, E., Ezzedine, K, Maza, A., Aujoulat, Isabelle, Le Rhun, Anne, and UCL - SSS/IRSS - Institut de recherche santé et société

Subjects
Questionnaires, Adult, Male, Health Status, Ichthyosis, Focus Groups, Middle Aged, Self Concept, Young Adult, Surveys and Questionnaires, Quality of Life, Humans, Female, Interpersonal Relations, Aged
Abstract

There is limited information regarding quality of life in patients with inherited ichthyosis.To identify factors influencing quality of life in patients with inherited ichthyosis.The study used focus groups and involved adult patients suffering from inherited ichthyosis from three French hospital centres. Group discussions were conducted by two facilitators and were continued until data saturation was reached. The verbatim transcripts were analysed independently by two investigators. Categories considered as key factors in the modulation of quality of life were negotiated until agreement was obtained.Data saturation was reached after the fifth group. A total of 25 patients affected by various forms of ichthyosis attended these focus groups. The identified factors influencing quality of life were related to physical health, daily life, relations with others or oneself. However, together with difficulties related to ichthyosis, patients also underlined some positive aspects of the disease and described specific measures used to improve their quality of life.This is the first study investigating the different factors that could impact quality of life in patients with ichthyosis. This provides an essential framework from which physicians can develop strategies to improve patient care and quality of life and to develop a specific quality of life questionnaire.

Published
2011

5. European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis

Author

Thyssen, J P, Vestergaard, C, Deleuran, M, de Bruin-Weller, M S, Bieber, T, Taieb, A, Seneschal, J, Cork, M J, Paul, C, Flohr, C, Weidinger, S, Trzeciak, M, Werfel, T, Heratizadeh, A, Barbarot, S, Darsow, U, Simon, D, Torrelo, A, Chernyshov, P V, Stalder, J-F, Gelmetti, C, Szalai, Z, Svensson, Å, von Kobyletzki, L B, De Raeve, L, Fölster-Holst, R, Cristen-Zaech, S, Hijnen, D, Gieler, U, Ring, J, and Wollenberg, A

Subjects
610 Medicine & health, 3. Good health

6. Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis

Author

Smith, M. J., Isidor, B., Christian Beetz, Williams, S. G., Bhaskar, S. S., Richer, W., O Sullivan, J., Anderson, B., Daly, S. B., Urquhart, J. E., Fryer, A., Rustad, C. F., Mills, S. J., Samii, A., Du Plessis, D., Halliday, D., Barbarot, S., Bourdeaut, F., Newman, W. G., and Evans, D. G.

7. European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

Author

Wollenberg, A, Flohr, C, Simon, Dagmar, Cork, M J, Thyssen, J P, Bieber, T, de Bruin-Weller, M S, Weidinger, S, Deleuran, M, Taieb, A, Paul, C, Trzeciak, M, Werfel, T, Seneschal, J, Barbarot, S, Darsow, U, Torrelo, A, Stalder, J-F, Svensson, Å, Hijnen, D, Gelmetti, C, Szalai, Z, Gieler, U, De Raeve, L, Kunz, B, Spuls, P, von Kobyletzki, L B, Fölster-Holst, R, Chernyshov, P V, Christen-Zaech, S, Heratizadeh, A, Ring, J, and Vestergaard, C

Subjects
610 Medicine & health, 3. Good health

10. Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients

Author

Jean Paul Fermand, Xavier Kyndt, Rita Rizzi, Erik Sauleau, Grateau G, Claire Blanchard-Delaunay, Stéphane Gayet, Agathe Masseau, Sébastien Barbarot, Xavier Puéchal, Dan Lipsker, Antoine Néel, L. Gusdorf, Bouchra Asli, François Lifermann, Didier Bessis, J.-E. Gottenberg, Boye T, F. Aubin, Franco Rongioletti, Gusdorf, L., Asli, B., Barbarot, S., Néel, A., Masseau, A., Puéchal, X., Gottenberg, J. -E., Grateau, G., Blanchard-Delaunay, C., Rizzi, R., Lifermann, F., Kyndt, X., Aubin, F., Bessis, D., Boye, T., Gayet, S., Rongioletti, F., Sauleau, E., Fermand, J. -P., and Lipsker, D

Subjects
Adult, Male, medicine.medical_specialty, Diagnostic criteria, Adolescent, Immunology, Disease, Periodic disease, Sensitivity and Specificity, Severity of Illness Index, Neutrophilic urticarial dermatosis, 030207 dermatology & venereal diseases, 03 medical and health sciences, Young Adult, Schnitzler syndrome, 0302 clinical medicine, Positive predicative value, medicine, Immunology and Allergy, In real life, Humans, In patient, Child, Schnitzler Syndrome, 030203 arthritis & rheumatology, business.industry, Monoclonal gammopathy, Reproducibility of Results, Auto-inflammatory disease, medicine.disease, Dermatology, Surgery, Urticarial rash, Child, Preschool, Female, medicine.symptom, Symptom Assessment, business
Abstract

Background Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical, histological, and biological signs of neutrophil-mediated inflammation. The aim of this study was to assess the applicability and validity of the existing diagnostic criteria in real-life patients. Methods This multicentric study was conducted between 2009 and 2014 in 14 hospitals in which patients with Schnitzler syndrome or controls with related disorders were followed up. We compared the sensitivities and specificities and calculated the positive and negative predictive values of the Lipsker and of the Strasbourg criteria for the patients with Schnitzler syndrome and for the controls. We included 42 patients with Schnitzler syndrome, 12 with adult-onset Still's disease, 7 with cryopyrin-associated periodic disease, 9 with Waldenstrom disease, and 10 with chronic spontaneous urticaria. Results All patients with Schnitzler syndrome met the Lipsker criteria. According to the Strasbourg criteria, 34 patients had definite Schnitzler syndrome, five had probable Schnitzler syndrome, and three did not meet the criteria. One control met the Lipsker criteria and had probable Schnitzler syndrome according to the Strasbourg criteria. Sensitivity and specificity of the Lipsker criteria were 100% and 97%, respectively. For the Strasbourg criteria, sensitivity for definite and probable diagnosis was 81% and 93%, respectively, with a corresponding specificity of 100% and 97%. Conclusion Diagnostic criteria currently in use to diagnose Schnitzler syndrome are reliable. More investigations must be done to attest their efficiency in patients with recent-onset manifestations.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results